409 results
DEFA14A
REGN
Regeneron Pharmaceuticals, Inc.
25 Apr 24
Additional proxy soliciting materials
4:02pm
. Sing
For
Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal
8-K
EX-99.1
9h0 wkidod
2 Feb 24
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
7:16am
8-K
EX-99.1
liudsmpvst4p1k 9q1a
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
8-K
EX-99.1
kwl 3z7ycat
2 Nov 23
Regeneron Reports Third Quarter 2023 Financial and Operating Results
7:10am
SC TO-T
EX-99
iryl0a5hp p5
25 Aug 23
Third party tender offer statement
7:46am
8-K
EX-99.1
peq4v
3 Aug 23
Regeneron Reports Second Quarter 2023 Financial and Operating Results
6:48am
8-K
4yrxy8lcu6m
14 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:07pm
8-K
EX-99.1
uige0en8y4040kb
4 May 23
Regeneron Reports First Quarter 2023 Financial and Operating Results
7:11am
DEFA14A
3h06c83d ger4
21 Apr 23
Additional proxy soliciting materials
4:03pm
8-K
rn1icl77mccl
17 Apr 23
Departure of Directors or Certain Officers
7:37am
8-K
EX-10.1
ounybcz01upfw4rnihj
29 Mar 23
Entry into a Material Definitive Agreement
4:01pm